Kirk William Johnson
CIK 1295678 · Chief Scientific Officer · last filed 2013-05-15
Kirk William Johnson is a Chief Scientific Officer who has filed 8 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for MNOV, was dated May 15, 2013. Current disclosed insider exposure totals $2.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.1K
2
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNOV | Chief Scientific Officer | 1,700 | $1.23 | $2.1K | $0 | 5 | 2013-05-15 |
| AVIGEN INC \DE (AVGN) Delisted | VP, Research & Development | — | — | — | $0 | 2 | 2007-12-07 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-15 | MNOV | Grant (A) | — | $0 | EDGAR |
| 2013-04-26 | MNOV | Grant (A) | — | $0 | EDGAR |
| 2011-04-06 | MNOV | Buy (P) | +1,700 | $0 | EDGAR |
| 2011-03-31 | MNOV | Buy (P) | +2,200 | $0 | EDGAR |
| 2010-02-03 | MNOV | Grant (A) | — | $0 | EDGAR |
| 2009-12-22 | — | Disp (D) | — | $0 | |
| 2007-12-07 | AVIGEN INC \DE (AVGN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-05 | AVIGEN INC \DE (AVGN) Delisted | Grant (A) | — | $0 | EDGAR |